Amgen (AMGN)
(Real Time Quote from BATS)
$336.82 USD
-0.56 (-0.17%)
Updated Sep 23, 2024 10:26 AM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Price, Consensus and EPS Surprise
AMGN 336.82 -0.56(-0.17%)
Will AMGN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AMGN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AMGN
NVO Stock Loses Around $29B in 3 Months: Buy the Dip or Steer Clear?
Amgen (AMGN) Stock Dips While Market Gains: Key Facts
AMGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
Amgen (AMGN) Rises Higher Than Market: Key Facts
VRDN Stock Soars as Eye Disorder Study Meets Primary Endpoints
Other News for AMGN
Unlocking Intrinsic Value: Analysis of Amgen Inc
Can These 5 Assets Skyrocket Your Portfolio?
Raise Cash And Sell Trash
Ideaya Biosciences Advances Synthetic Lethality With IDE397 Success
Janus Henderson Global Life Sciences Fund Q2 2024 Commentary